Literature DB >> 20484043

Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.

Hakeemah Al-Nakhle1, Philip A Burns, Michele Cummings, Andrew M Hanby, Thomas A Hughes, Sampoorna Satheesha, Abeer M Shaaban, Laura Smith, Valerie Speirs.   

Abstract

Estrogen receptor beta1 (ERbeta1) downregulation occurs in many breast cancers, but the responsible molecular mechanisms remain unclear. Here, we report that levels of ERbeta1 expression are negatively regulated by the microRNA miR-92. Expression analysis in a cohort of primary breast tumors confirmed a significant negative correlation between miR-92 and both ERbeta1 mRNA and protein. Inhibition of miR-92 in MCF-7 cells increased ERbeta1 expression in a dose-dependent manner, whereas miR-92 overexpression led to ERbeta1 downregulation. Reporter constructs containing candidate miR-92 binding sites in the 3'-untranslated region (UTR) of ERbeta1 suggested by bioinformatics analysis confirmed that miR-92 downregulated ERbeta1 via direct targeting of its 3'-UTR. Our results define a potentially important mechanism for downregulation of ERbeta1 expression in breast cancer. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484043      PMCID: PMC2883739          DOI: 10.1158/0008-5472.CAN-09-4104

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

Review 1.  The complexities of microRNA regulation: mirandering around the rules.

Authors:  Kimberly Breving; Aurora Esquela-Kerscher
Journal:  Int J Biochem Cell Biol       Date:  2009-09-30       Impact factor: 5.085

2.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

3.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Authors:  Ping Mu; Yoon-Chi Han; Doron Betel; Evelyn Yao; Massimo Squatrito; Paul Ogrodowski; Elisa de Stanchina; Aleco D'Andrea; Chris Sander; Andrea Ventura
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

4.  Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.

Authors:  Chunyan Zhao; Eric W-F Lam; Andrew Sunters; Eva Enmark; Manuela Tamburo De Bella; R Charles Coombes; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  Oncogene       Date:  2003-10-23       Impact factor: 9.867

5.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Authors:  Naoto Kondo; Tatsuya Toyama; Hiroshi Sugiura; Yoshitaka Fujii; Hiroko Yamashita
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

6.  Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression.

Authors:  Olga Kovalchuk; Volodymyr P Tryndyak; Beverly Montgomery; Alex Boyko; Kristy Kutanzi; Franz Zemp; Alan R Warbritton; John R Latendresse; Igor Kovalchuk; Frederick A Beland; Igor P Pogribny
Journal:  Cell Cycle       Date:  2007-06-06       Impact factor: 4.534

7.  Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen.

Authors:  Loaie Maraqa; Michele Cummings; Mark B Peter; Abeer M Shaaban; Kieran Horgan; Andrew M Hanby; Valerie Speirs
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

8.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.

Authors:  B Diosdado; M A van de Wiel; J S Terhaar Sive Droste; S Mongera; C Postma; W J H J Meijerink; B Carvalho; G A Meijer
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

10.  Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.

Authors:  Abeer M Shaaban; Andrew R Green; Suchita Karthik; Yalda Alizadeh; Thomas A Hughes; Lynn Harkins; Ian O Ellis; John F Robertson; Emma C Paish; Philippa T K Saunders; Nigel P Groome; Valerie Speirs
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

View more
  52 in total

Review 1.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

2.  Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia.

Authors:  M Sharifi; R Salehi
Journal:  Cancer Gene Ther       Date:  2015-12-11       Impact factor: 5.987

3.  PPARα is regulated by miR-21 and miR-27b in human liver.

Authors:  Katsuhiko Kida; Miki Nakajima; Takuya Mohri; Yuki Oda; Shingo Takagi; Tatsuki Fukami; Tsuyoshi Yokoi
Journal:  Pharm Res       Date:  2011-05-12       Impact factor: 4.200

4.  Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.

Authors:  Lin Zhao; Zhaojin Yu; Yunan Li; Xiaoyan Wen; Wenfeng Ma; Lin Wang; Jie Ren; Caigang Liu; Miao He; Xuefeng Bai; Mingli Sun; Zhihong Zheng; Xiaoyi Mi; Enhua Wang; Olufunmilayo I Olopade; Feng Jin; Minjie Wei
Journal:  Med Oncol       Date:  2011-11-22       Impact factor: 3.064

5.  miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Authors:  Kun Wang; Xuan Wang; Jian Zou; Anling Zhang; Yingfeng Wan; Peiyu Pu; Zhengfei Song; Cong Qian; Yili Chen; Shuxu Yang; Yirong Wang
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

Review 6.  miRNAs and estrogen action.

Authors:  Carolyn M Klinge
Journal:  Trends Endocrinol Metab       Date:  2012-04-11       Impact factor: 12.015

7.  MicroRNA Regulatory Networks Provide Feedback Mechanisms for Steroid Receptor Signaling.

Authors:  Qun Zhou; Gabriel Eades
Journal:  J Steroids Horm Sci       Date:  2012-03-17

8.  MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR.

Authors:  Jian-Hua Duan; Long Fang
Journal:  Tumour Biol       Date:  2014-08-06

Review 9.  Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.

Authors:  Siuwah Tang; Jillian Bonaroti; Sebnem Unlu; Xiaoyan Liang; Daolin Tang; Herbert J Zeh; Michael T Lotze
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

Review 10.  Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention.

Authors:  Alberto Izzotti; Stefano Carozzo; Alessandra Pulliero; Dinara Zhabayeva; Jean Louis Ravetti; Rakhmet Bersimbaev
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.